| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |